Skip To Main Content
Parkinnova Therapeutics on Muck Rack

Parkinnova Therapeutics

As seen in: Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Parkinnova

Contact Parkinnova, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Boosting endogenous dopamine production: a novel therapeutic approach for Parkinson’s disease

|
By Erik H. Douma, Marten Smidt, Parkinnova Therapeutics
| Cell Press Verified
Innovative therapeutic strategies are urgently needed for Parkinson’s disease due to limited efficacy of current treatments and a weak therapeutic pipeline. In this forum article, we propose targeting tyrosine hydroxylase phosphorylation as a novel mechanism of action to address this critical need.
Open in Who Shared Issue with article?
See all 1 articles